Q66479 · POLG_HE71M
- ProteinGenome polyprotein
- StatusUniProtKB reviewed (Swiss-Prot)
- Amino acids2193 (go to sequence)
- Protein existenceEvidence at protein level
- Annotation score5/5
Function
function
Capsid protein VP1
Forms an icosahedral capsid of pseudo T=3 symmetry with capsid proteins VP2 and VP3 (By similarity).
The capsid is 300 Angstroms in diameter, composed of 60 copies of each capsid protein and enclosing the viral positive strand RNA genome (By similarity).
Capsid protein VP1 mainly forms the vertices of the capsid (By similarity).
Capsid protein VP1, together with VP2, interacts with host cell receptor SCARB2 to provide virion attachment to target host cells (PubMed:30531980).
This attachment induces virion internalization (By similarity).
After binding to its receptor, the capsid undergoes conformational changes (By similarity).
Capsid protein VP1 N-terminus (that contains an amphipathic alpha-helix) and capsid protein VP4 are externalized (By similarity).
Together, they shape a pore in the host membrane through which viral genome is translocated to host cell cytoplasm (By similarity).
The capsid is 300 Angstroms in diameter, composed of 60 copies of each capsid protein and enclosing the viral positive strand RNA genome (By similarity).
Capsid protein VP1 mainly forms the vertices of the capsid (By similarity).
Capsid protein VP1, together with VP2, interacts with host cell receptor SCARB2 to provide virion attachment to target host cells (PubMed:30531980).
This attachment induces virion internalization (By similarity).
After binding to its receptor, the capsid undergoes conformational changes (By similarity).
Capsid protein VP1 N-terminus (that contains an amphipathic alpha-helix) and capsid protein VP4 are externalized (By similarity).
Together, they shape a pore in the host membrane through which viral genome is translocated to host cell cytoplasm (By similarity).
Capsid protein VP2
Forms an icosahedral capsid of pseudo T=3 symmetry with capsid proteins VP2 and VP3 (By similarity).
The capsid is 300 Angstroms in diameter, composed of 60 copies of each capsid protein and enclosing the viral positive strand RNA genome (By similarity).
Capsid protein VP2, together with VP1, interacts with host cell receptor SCARB2 to provide virion attachment to target host cells (PubMed:30531980).
The capsid is 300 Angstroms in diameter, composed of 60 copies of each capsid protein and enclosing the viral positive strand RNA genome (By similarity).
Capsid protein VP2, together with VP1, interacts with host cell receptor SCARB2 to provide virion attachment to target host cells (PubMed:30531980).
Capsid protein VP3
Forms an icosahedral capsid of pseudo T=3 symmetry with capsid proteins VP2 and VP3 (By similarity).
The capsid is 300 Angstroms in diameter, composed of 60 copies of each capsid protein and enclosing the viral positive strand RNA genome (By similarity).
The capsid is 300 Angstroms in diameter, composed of 60 copies of each capsid protein and enclosing the viral positive strand RNA genome (By similarity).
Capsid protein VP4
Lies on the inner surface of the capsid shell (By similarity).
After binding to the host receptor, the capsid undergoes conformational changes (By similarity).
Capsid protein VP4 is released, Capsid protein VP1 N-terminus is externalized, and together, they shape a pore in the host membrane through which the viral genome is translocated into the host cell cytoplasm (By similarity).
After binding to the host receptor, the capsid undergoes conformational changes (By similarity).
Capsid protein VP4 is released, Capsid protein VP1 N-terminus is externalized, and together, they shape a pore in the host membrane through which the viral genome is translocated into the host cell cytoplasm (By similarity).
Capsid protein VP0
Component of immature procapsids, which is cleaved into capsid proteins VP4 and VP2 after maturation (By similarity).
Allows the capsid to remain inactive before the maturation step (By similarity).
Allows the capsid to remain inactive before the maturation step (By similarity).
Protease 2A
Cysteine protease that cleaves viral polyprotein and specific host proteins (By similarity).
It is responsible for the autocatalytic cleavage between the P1 and P2 regions, which is the first cleavage occurring in the polyprotein (By similarity).
Cleaves also the host translation initiation factor EIF4G1, in order to shut down the capped cellular mRNA translation (By similarity).
Inhibits the host nucleus-cytoplasm protein and RNA trafficking by cleaving host members of the nuclear pores (By similarity).
Counteracts stress granule formation probably by antagonizing its assembly or promoting its dissassembly (By similarity).
Cleaves and inhibits host IFIH1/MDA5, thereby inhibiting the type-I IFN production and the establishment of the antiviral state (By similarity).
Cleaves and inhibits host MAVS, thereby inhibiting the type-I IFN production and the establishment of the antiviral state (By similarity).
It is responsible for the autocatalytic cleavage between the P1 and P2 regions, which is the first cleavage occurring in the polyprotein (By similarity).
Cleaves also the host translation initiation factor EIF4G1, in order to shut down the capped cellular mRNA translation (By similarity).
Inhibits the host nucleus-cytoplasm protein and RNA trafficking by cleaving host members of the nuclear pores (By similarity).
Counteracts stress granule formation probably by antagonizing its assembly or promoting its dissassembly (By similarity).
Cleaves and inhibits host IFIH1/MDA5, thereby inhibiting the type-I IFN production and the establishment of the antiviral state (By similarity).
Cleaves and inhibits host MAVS, thereby inhibiting the type-I IFN production and the establishment of the antiviral state (By similarity).
Protein 2B
Plays an essential role in the virus replication cycle by acting as a viroporin. Creates a pore in the host reticulum endoplasmic and as a consequence releases Ca2+ in the cytoplasm of infected cell. In turn, high levels of cytoplasmic calcium may trigger membrane trafficking and transport of viral ER-associated proteins to viroplasms, sites of viral genome replication.
Protein 2C
Induces and associates with structural rearrangements of intracellular membranes. Displays RNA-binding, nucleotide binding and NTPase activities. May play a role in virion morphogenesis and viral RNA encapsidation by interacting with the capsid protein VP3.
Protein 3AB
Localizes the viral replication complex to the surface of membranous vesicles. Together with protein 3CD binds the Cis-Active RNA Element (CRE) which is involved in RNA synthesis initiation. Acts as a cofactor to stimulate the activity of 3D polymerase, maybe through a nucleid acid chaperone activity.
Protein 3A
Localizes the viral replication complex to the surface of membranous vesicles (By similarity).
It inhibits host cell endoplasmic reticulum-to-Golgi apparatus transport and causes the disassembly of the Golgi complex, possibly through GBF1 interaction (By similarity).
This would result in depletion of MHC, trail receptors and IFN receptors at the host cell surface (By similarity).
Plays an essential role in viral RNA replication by recruiting ACBD3 and PI4KB at the viral replication sites, thereby allowing the formation of the rearranged membranous structures where viral replication takes place (Probable)
It inhibits host cell endoplasmic reticulum-to-Golgi apparatus transport and causes the disassembly of the Golgi complex, possibly through GBF1 interaction (By similarity).
This would result in depletion of MHC, trail receptors and IFN receptors at the host cell surface (By similarity).
Plays an essential role in viral RNA replication by recruiting ACBD3 and PI4KB at the viral replication sites, thereby allowing the formation of the rearranged membranous structures where viral replication takes place (Probable)
Viral protein genome-linked
Acts as a primer for viral RNA replication and remains covalently bound to viral genomic RNA. VPg is uridylylated prior to priming replication into VPg-pUpU (By similarity).
The oriI viral genomic sequence may act as a template for this. The VPg-pUpU is then used as primer on the genomic RNA poly(A) by the RNA-dependent RNA polymerase to replicate the viral genome (By similarity).
Following genome release from the infecting virion in the cytoplasm, the VPg-RNA linkage is probably removed by host TDP2 (By similarity).
During the late stage of the replication cycle, host TDP2 is excluded from sites of viral RNA synthesis and encapsidation, allowing for the generation of progeny virions (By similarity).
The oriI viral genomic sequence may act as a template for this. The VPg-pUpU is then used as primer on the genomic RNA poly(A) by the RNA-dependent RNA polymerase to replicate the viral genome (By similarity).
Following genome release from the infecting virion in the cytoplasm, the VPg-RNA linkage is probably removed by host TDP2 (By similarity).
During the late stage of the replication cycle, host TDP2 is excluded from sites of viral RNA synthesis and encapsidation, allowing for the generation of progeny virions (By similarity).
Protein 3CD
Involved in the viral replication complex and viral polypeptide maturation. It exhibits protease activity with a specificity and catalytic efficiency that is different from protease 3C. Protein 3CD lacks polymerase activity. Protein 3CD binds to the 5'UTR of the viral genome.
Protease 3C
Major viral protease that mediates proteolytic processing of the polyprotein (By similarity).
Cleaves host EIF5B, contributing to host translation shutoff (By similarity).
Cleaves also host PABPC1, contributing to host translation shutoff (By similarity).
Disassembles host cytoplasmic stress granules by cleaving host G3BP1, although this effect is less prononced than the inhibition induced by protease 2A (By similarity).
Cleaves host RIGI and thus contributes to the inhibition of type I interferon production (By similarity).
Cleaves host IRF7 and thus contributes to the inhibition of type I interferon production (By similarity).
Cleaves host HNRNPA1 thereby increasing the translation of apoptosis protease activating factor APAF1, leading to apoptosis of the host cell (By similarity).
Cleaves host NLRP1, triggers host N-glycine-mediated degradation of the autoinhibitory NLRP1 N-terminal fragment (By similarity).
Cleaves host EIF5B, contributing to host translation shutoff (By similarity).
Cleaves also host PABPC1, contributing to host translation shutoff (By similarity).
Disassembles host cytoplasmic stress granules by cleaving host G3BP1, although this effect is less prononced than the inhibition induced by protease 2A (By similarity).
Cleaves host RIGI and thus contributes to the inhibition of type I interferon production (By similarity).
Cleaves host IRF7 and thus contributes to the inhibition of type I interferon production (By similarity).
Cleaves host HNRNPA1 thereby increasing the translation of apoptosis protease activating factor APAF1, leading to apoptosis of the host cell (By similarity).
Cleaves host NLRP1, triggers host N-glycine-mediated degradation of the autoinhibitory NLRP1 N-terminal fragment (By similarity).
RNA-directed RNA polymerase
Replicates the viral genomic RNA on the surface of intracellular membranes. May form linear arrays of subunits that propagate along a strong head-to-tail interaction called interface-I. Covalently attaches UMP to a tyrosine of VPg, which is used to prime RNA synthesis. The positive stranded RNA genome is first replicated at virus induced membranous vesicles, creating a dsRNA genomic replication form. This dsRNA is then used as template to synthesize positive stranded RNA genomes. ss+RNA genomes are either translated, replicated or encapsidated.
Catalytic activity
Protein 2C
a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+Protease 2A
Selective cleavage of Tyr-|-Gly bond in the picornavirus polyprotein.RNA-directed RNA polymerase
RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphateProtease 3C
Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
Cofactor
RNA-directed RNA polymerase
Mg2+ (UniProtKB | Rhea| CHEBI:18420 )Note: Binds 2 magnesium ions that constitute a dinuclear catalytic metal center (By similarity).
The magnesium ions are not prebound but only present for catalysis (By similarity).
Requires the presence of 3CDpro or 3CPro (By similarity).
The magnesium ions are not prebound but only present for catalysis (By similarity).
Requires the presence of 3CDpro or 3CPro (By similarity).
Activity regulation
RNA-directed RNA polymerase
Replication or transcription is subject to high level of random mutations by the nucleotide analog ribavirin.
Features
Showing features for site, active site, binding site.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Site | 69-70 | Cleavage; by autolysis | ||||
Sequence: KS | ||||||
Site | 323-324 | Cleavage; by protease 3C | ||||
Sequence: QG | ||||||
Site | 862-863 | Cleavage; by autolysis | ||||
Sequence: LG | ||||||
Active site | 883 | For protease 2A activity | ||||
Sequence: H | ||||||
Active site | 901 | For protease 2A activity | ||||
Sequence: D | ||||||
Binding site | 918 | Zn2+ 1 (UniProtKB | ChEBI); structural | ||||
Sequence: C | ||||||
Binding site | 920 | Zn2+ 1 (UniProtKB | ChEBI); structural | ||||
Sequence: C | ||||||
Active site | 972 | For protease 2A activity | ||||
Sequence: C | ||||||
Binding site | 978 | Zn2+ 1 (UniProtKB | ChEBI); structural | ||||
Sequence: C | ||||||
Binding site | 980 | Zn2+ 1 (UniProtKB | ChEBI); structural | ||||
Sequence: H | ||||||
Site | 1012-1013 | Cleavage; by protease 3C | ||||
Sequence: QG | ||||||
Site | 1111-1112 | Cleavage; by protease 3C | ||||
Sequence: QS | ||||||
Site | 1136 | Involved in the interaction with host RTN3 | ||||
Sequence: I | ||||||
Binding site | 1240-1247 | ATP (UniProtKB | ChEBI) | ||||
Sequence: GSPGTGKS | ||||||
Binding site | 1381 | Zn2+ 2 (UniProtKB | ChEBI) | ||||
Sequence: C | ||||||
Binding site | 1392 | Zn2+ 2 (UniProtKB | ChEBI) | ||||
Sequence: C | ||||||
Binding site | 1397 | Zn2+ 2 (UniProtKB | ChEBI) | ||||
Sequence: C | ||||||
Site | 1440-1441 | Cleavage; by protease 3C | ||||
Sequence: QG | ||||||
Site | 1526-1527 | Cleavage; by protease 3C | ||||
Sequence: QG | ||||||
Site | 1548-1549 | Cleavage; by protease 3C | ||||
Sequence: QG | ||||||
Active site | 1588 | For protease 3C activity | ||||
Sequence: H | ||||||
Active site | 1619 | For protease 3C activity | ||||
Sequence: E | ||||||
Active site | 1695 | For protease 3C activity | ||||
Sequence: C | ||||||
Site | 1731-1732 | Cleavage; by protease 3C | ||||
Sequence: QG | ||||||
Binding site | 1964 | Mg2+ 1 (UniProtKB | ChEBI); catalytic; for RdRp activity | ||||
Sequence: D | ||||||
Binding site | 1964 | Mg2+ 2 (UniProtKB | ChEBI); catalytic; for RdRp activity | ||||
Sequence: D | ||||||
Binding site | 2060 | Mg2+ 1 (UniProtKB | ChEBI); catalytic; for RdRp activity | ||||
Sequence: D | ||||||
Binding site | 2060 | Mg2+ 2 (UniProtKB | ChEBI); catalytic; for RdRp activity | ||||
Sequence: D |
GO annotations
Keywords
- Molecular function
- Biological process
- Ligand
Enzyme and pathway databases
Protein family/group databases
Names & Taxonomy
Protein names
- Recommended nameGenome polyprotein
- Cleaved into 17 chains
Organism names
- Taxonomic lineageViruses > Riboviria > Orthornavirae > Pisuviricota > Pisoniviricetes > Picornavirales > Picornaviridae > Ensavirinae > Enterovirus > Enterovirus A
- Virus hosts
Accessions
- Primary accessionQ66479
Proteomes
Subcellular Location
UniProt Annotation
GO Annotation
Capsid protein VP0
Capsid protein VP4
Capsid protein VP2
Capsid protein VP3
Capsid protein VP1
Protein 2B
Host cytoplasmic vesicle membrane ; Peripheral membrane protein
Note: Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum.
Protein 2C
Host cytoplasmic vesicle membrane ; Peripheral membrane protein
Note: Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum.
Protein 3A
Host cytoplasmic vesicle membrane ; Peripheral membrane protein
Note: Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum.
Protein 3AB
Host cytoplasmic vesicle membrane ; Peripheral membrane protein
Note: Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum.
Viral protein genome-linked
Protease 3C
Protein 3CD
Host cytoplasmic vesicle membrane ; Peripheral membrane protein
Note: Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum.
RNA-directed RNA polymerase
Host cytoplasmic vesicle membrane ; Peripheral membrane protein
Note: Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum.
Features
Showing features for topological domain, intramembrane.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Topological domain | 2-1503 | Cytoplasmic | ||||
Sequence: GSQVSTQRSGSHENSNSATEGSTINYTTINYYKDSYAATAGKQSLKQDPDKFANPVKDIFTEMAAPLKSPSAEACGYSDRVAQLTIGNSTITTQEAANIIVGYGEWPSYCSDDDATAVDKPTRPDVSVNRFYTLDTKLWEKSSKGWYWKFPDVLTETGVFGQNAQFHYLYRSGFCIHVQCNASKFHQGALLVAILPEYVIGTVAGGTGTEDSHPPYKQTQPGADGFELQHPYVLDAGIPISQLTVCPHQWINLRTNNCATIIVPYMNTLPFDSALNHCNFGLLVVPISPLDFDQGATPVIPITITLAPMCSEFGGLRQAVTQGFPTELKPGTNQFLTTDDGVSAPILPNFHPTPCIHIPGEVRNLLELCQVETILEVNNVPTNATSLMERLRFPVSAQAGKGELCAVFRADPGRDGPWQSTMLGQLCGYYTQWSGSLEVTFMFTGSFMATGKMLIAYTPPGGPLPKDRATAMLGTHVIWDFGLQSSVTLVIPWISNTHYRAHARDGVFDYYTTGLVSIWYQTNYVVPIGAPNTAYILALAAAQKNFTMKLCKDTSHILQTASIQGDRVADVIESSIGDSVSRALTQALPAPTGQNTQVSSHRLDTGEVPALQAAEIGASSNTSDESMIETRCVLNSHSTAETTLDSFFSRAGLVGEIDLPLEGTTNPNGYANWDIDITGYAQMRRKVELFTYMRFDAEFTFVACTPTGEVVPQLLQYMFVPPGAPKPESRESLAWQTATNPSVFVKLTDPPAQVSVPFMSPASAYQWFYDGYPTFGEHKQEKDLEYGACPNNMMGTFSVRTVGSSKSKYPLVVRIYMRMKHVRAWIPRPMRNQNYLFKANPNYAGNSIKPTGTSRNAITTLGKFGQQSGAIYVGNFRVVNRHLATHNDWANLVWEDSSRDLLVSSTTAQGCDTIARCNCQTGVYYCNSKRKHYPVSFSKPSLIYVEASEYYPARYQSHLMLAAGHSESGDCGGILRCQHGVVGIASTGGNGLVGFADVRDLLWLDEEAMEQGVSDYIKGLGDAFGTGFTDAVSREVEALRNHLIGSDGAVEKILKNLIKLISALVIVIRSDYDMVTLTATLALIGCHGSPWAWIKAKTASILGIPIAQKQSASWLKKFNDMASAAKGLEWISNKISKFIDWLREKIVPAAKEKAEFLTNLKQFPLLENQITHLEQSAASQEDLEAMFGNVSYLAHFCRKFQPLYATEAKRVYVLEKRMNNYMQFKSTHRIEPVCLIIRGSPGTGKSLATGIIARAIADKYHSSVYSLPPDPDHFDGYKQQVVTVMDDLCQNPDGKDMSLFYQMVSTVDIIPPMASLEEKGVSFTSKFVIASTNASNIIVPTVSDSDAIRRRFYMDCDIEVTDSSKTDLGRLDAGRAAKLCSENNTANFKRCSPLVCGKAIQLRDRKSKVRYSVDTVVSELIREYNSRSAIGNTIEALFQGPPKFRPIRISLEEKPAPDAISDLLASVDSEEVRQYCREQGWIIPETPTNVERHLNRAVLVMQ | ||||||
Intramembrane | 1504-1519 | |||||
Sequence: SIATVVAVVSLVYVIY | ||||||
Topological domain | 1520-2193 | Cytoplasmic | ||||
Sequence: KLFAGFQGAYSGAPNQVLKKPVLRTATVQGPSLDFALSLLRRNIRQVQTDQGHFTMLGVRDRLAVLPRHSQPGKTIWVEHKLVNILDAAELVDEQGVNLELTLVTLDTNEKFRDITKFIPETISGASDATLVINTEHMPSMFVPVGDVVQYGFLNLSGKPTHRTMMYNFPTKAGQCGGVVTSVGKIIGIHIGGNGRQGFCAGLKRSYFASEQGEIQWVKSNKETGRLNINGPTRTKLEPSVFHDVFEANKEPAVLTSKDPRLEVDFEQALFSKYVGNVLHEPDEYVHQAALHYANQLKQLDINTKKMSMEEACYGTDNLEAIDLHTSAGYPYSALGIKKRDILDPATRDVSKMKSYMDKYGLDLPYSTYVKDELRSLDKIKKGKSRLIEASSLNDSVYLRMTFGHLYEVFHANPGTVTGSAVGCNPDVFWSKLPILLPGSLFAFDYSGYDASLSPVWFRALEVVLREIGYSEEAVSLIEGINHTHHIYRNKTYCVLGGMPSGCSGTSIFNSMINNIIIRTLLIKTFKGIDLDELNMVAYGDDVLASYPFPIDCLELAKTGKEYGLTMTPAGKSPCFNEVTWENATFLKRGFLPDHQFPFLIHPTMPMKEIHESIRWTKDARNTQDHVRSLCLLAWHNGKDEYEKFVSTIRSVPVGKALAIPNFENLRRNWLELF |
Keywords
- Cellular component
PTM/Processing
Features
Showing features for initiator methionine, lipidation, chain, modified residue.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Initiator methionine | 1 | Removed; by host | ||||
Sequence: M | ||||||
Lipidation | 2 | N-myristoyl glycine; by host | ||||
Sequence: G | ||||||
Chain | PRO_0000426153 | 2-69 | Capsid protein VP4 | |||
Sequence: GSQVSTQRSGSHENSNSATEGSTINYTTINYYKDSYAATAGKQSLKQDPDKFANPVKDIFTEMAAPLK | ||||||
Chain | PRO_0000426152 | 2-323 | Capsid protein VP0 | |||
Sequence: GSQVSTQRSGSHENSNSATEGSTINYTTINYYKDSYAATAGKQSLKQDPDKFANPVKDIFTEMAAPLKSPSAEACGYSDRVAQLTIGNSTITTQEAANIIVGYGEWPSYCSDDDATAVDKPTRPDVSVNRFYTLDTKLWEKSSKGWYWKFPDVLTETGVFGQNAQFHYLYRSGFCIHVQCNASKFHQGALLVAILPEYVIGTVAGGTGTEDSHPPYKQTQPGADGFELQHPYVLDAGIPISQLTVCPHQWINLRTNNCATIIVPYMNTLPFDSALNHCNFGLLVVPISPLDFDQGATPVIPITITLAPMCSEFGGLRQAVTQ | ||||||
Chain | PRO_0000426151 | 2-862 | P1 | |||
Sequence: GSQVSTQRSGSHENSNSATEGSTINYTTINYYKDSYAATAGKQSLKQDPDKFANPVKDIFTEMAAPLKSPSAEACGYSDRVAQLTIGNSTITTQEAANIIVGYGEWPSYCSDDDATAVDKPTRPDVSVNRFYTLDTKLWEKSSKGWYWKFPDVLTETGVFGQNAQFHYLYRSGFCIHVQCNASKFHQGALLVAILPEYVIGTVAGGTGTEDSHPPYKQTQPGADGFELQHPYVLDAGIPISQLTVCPHQWINLRTNNCATIIVPYMNTLPFDSALNHCNFGLLVVPISPLDFDQGATPVIPITITLAPMCSEFGGLRQAVTQGFPTELKPGTNQFLTTDDGVSAPILPNFHPTPCIHIPGEVRNLLELCQVETILEVNNVPTNATSLMERLRFPVSAQAGKGELCAVFRADPGRDGPWQSTMLGQLCGYYTQWSGSLEVTFMFTGSFMATGKMLIAYTPPGGPLPKDRATAMLGTHVIWDFGLQSSVTLVIPWISNTHYRAHARDGVFDYYTTGLVSIWYQTNYVVPIGAPNTAYILALAAAQKNFTMKLCKDTSHILQTASIQGDRVADVIESSIGDSVSRALTQALPAPTGQNTQVSSHRLDTGEVPALQAAEIGASSNTSDESMIETRCVLNSHSTAETTLDSFFSRAGLVGEIDLPLEGTTNPNGYANWDIDITGYAQMRRKVELFTYMRFDAEFTFVACTPTGEVVPQLLQYMFVPPGAPKPESRESLAWQTATNPSVFVKLTDPPAQVSVPFMSPASAYQWFYDGYPTFGEHKQEKDLEYGACPNNMMGTFSVRTVGSSKSKYPLVVRIYMRMKHVRAWIPRPMRNQNYLFKANPNYAGNSIKPTGTSRNAITTL | ||||||
Chain | PRO_0000426150 | 2-2193 | Genome polyprotein | |||
Sequence: GSQVSTQRSGSHENSNSATEGSTINYTTINYYKDSYAATAGKQSLKQDPDKFANPVKDIFTEMAAPLKSPSAEACGYSDRVAQLTIGNSTITTQEAANIIVGYGEWPSYCSDDDATAVDKPTRPDVSVNRFYTLDTKLWEKSSKGWYWKFPDVLTETGVFGQNAQFHYLYRSGFCIHVQCNASKFHQGALLVAILPEYVIGTVAGGTGTEDSHPPYKQTQPGADGFELQHPYVLDAGIPISQLTVCPHQWINLRTNNCATIIVPYMNTLPFDSALNHCNFGLLVVPISPLDFDQGATPVIPITITLAPMCSEFGGLRQAVTQGFPTELKPGTNQFLTTDDGVSAPILPNFHPTPCIHIPGEVRNLLELCQVETILEVNNVPTNATSLMERLRFPVSAQAGKGELCAVFRADPGRDGPWQSTMLGQLCGYYTQWSGSLEVTFMFTGSFMATGKMLIAYTPPGGPLPKDRATAMLGTHVIWDFGLQSSVTLVIPWISNTHYRAHARDGVFDYYTTGLVSIWYQTNYVVPIGAPNTAYILALAAAQKNFTMKLCKDTSHILQTASIQGDRVADVIESSIGDSVSRALTQALPAPTGQNTQVSSHRLDTGEVPALQAAEIGASSNTSDESMIETRCVLNSHSTAETTLDSFFSRAGLVGEIDLPLEGTTNPNGYANWDIDITGYAQMRRKVELFTYMRFDAEFTFVACTPTGEVVPQLLQYMFVPPGAPKPESRESLAWQTATNPSVFVKLTDPPAQVSVPFMSPASAYQWFYDGYPTFGEHKQEKDLEYGACPNNMMGTFSVRTVGSSKSKYPLVVRIYMRMKHVRAWIPRPMRNQNYLFKANPNYAGNSIKPTGTSRNAITTLGKFGQQSGAIYVGNFRVVNRHLATHNDWANLVWEDSSRDLLVSSTTAQGCDTIARCNCQTGVYYCNSKRKHYPVSFSKPSLIYVEASEYYPARYQSHLMLAAGHSESGDCGGILRCQHGVVGIASTGGNGLVGFADVRDLLWLDEEAMEQGVSDYIKGLGDAFGTGFTDAVSREVEALRNHLIGSDGAVEKILKNLIKLISALVIVIRSDYDMVTLTATLALIGCHGSPWAWIKAKTASILGIPIAQKQSASWLKKFNDMASAAKGLEWISNKISKFIDWLREKIVPAAKEKAEFLTNLKQFPLLENQITHLEQSAASQEDLEAMFGNVSYLAHFCRKFQPLYATEAKRVYVLEKRMNNYMQFKSTHRIEPVCLIIRGSPGTGKSLATGIIARAIADKYHSSVYSLPPDPDHFDGYKQQVVTVMDDLCQNPDGKDMSLFYQMVSTVDIIPPMASLEEKGVSFTSKFVIASTNASNIIVPTVSDSDAIRRRFYMDCDIEVTDSSKTDLGRLDAGRAAKLCSENNTANFKRCSPLVCGKAIQLRDRKSKVRYSVDTVVSELIREYNSRSAIGNTIEALFQGPPKFRPIRISLEEKPAPDAISDLLASVDSEEVRQYCREQGWIIPETPTNVERHLNRAVLVMQSIATVVAVVSLVYVIYKLFAGFQGAYSGAPNQVLKKPVLRTATVQGPSLDFALSLLRRNIRQVQTDQGHFTMLGVRDRLAVLPRHSQPGKTIWVEHKLVNILDAAELVDEQGVNLELTLVTLDTNEKFRDITKFIPETISGASDATLVINTEHMPSMFVPVGDVVQYGFLNLSGKPTHRTMMYNFPTKAGQCGGVVTSVGKIIGIHIGGNGRQGFCAGLKRSYFASEQGEIQWVKSNKETGRLNINGPTRTKLEPSVFHDVFEANKEPAVLTSKDPRLEVDFEQALFSKYVGNVLHEPDEYVHQAALHYANQLKQLDINTKKMSMEEACYGTDNLEAIDLHTSAGYPYSALGIKKRDILDPATRDVSKMKSYMDKYGLDLPYSTYVKDELRSLDKIKKGKSRLIEASSLNDSVYLRMTFGHLYEVFHANPGTVTGSAVGCNPDVFWSKLPILLPGSLFAFDYSGYDASLSPVWFRALEVVLREIGYSEEAVSLIEGINHTHHIYRNKTYCVLGGMPSGCSGTSIFNSMINNIIIRTLLIKTFKGIDLDELNMVAYGDDVLASYPFPIDCLELAKTGKEYGLTMTPAGKSPCFNEVTWENATFLKRGFLPDHQFPFLIHPTMPMKEIHESIRWTKDARNTQDHVRSLCLLAWHNGKDEYEKFVSTIRSVPVGKALAIPNFENLRRNWLELF | ||||||
Chain | PRO_0000426154 | 70-323 | Capsid protein VP2 | |||
Sequence: SPSAEACGYSDRVAQLTIGNSTITTQEAANIIVGYGEWPSYCSDDDATAVDKPTRPDVSVNRFYTLDTKLWEKSSKGWYWKFPDVLTETGVFGQNAQFHYLYRSGFCIHVQCNASKFHQGALLVAILPEYVIGTVAGGTGTEDSHPPYKQTQPGADGFELQHPYVLDAGIPISQLTVCPHQWINLRTNNCATIIVPYMNTLPFDSALNHCNFGLLVVPISPLDFDQGATPVIPITITLAPMCSEFGGLRQAVTQ | ||||||
Chain | PRO_0000426155 | 324-565 | Capsid protein VP3 | |||
Sequence: GFPTELKPGTNQFLTTDDGVSAPILPNFHPTPCIHIPGEVRNLLELCQVETILEVNNVPTNATSLMERLRFPVSAQAGKGELCAVFRADPGRDGPWQSTMLGQLCGYYTQWSGSLEVTFMFTGSFMATGKMLIAYTPPGGPLPKDRATAMLGTHVIWDFGLQSSVTLVIPWISNTHYRAHARDGVFDYYTTGLVSIWYQTNYVVPIGAPNTAYILALAAAQKNFTMKLCKDTSHILQTASIQ | ||||||
Chain | PRO_0000426156 | 566-862 | Capsid protein VP1 | |||
Sequence: GDRVADVIESSIGDSVSRALTQALPAPTGQNTQVSSHRLDTGEVPALQAAEIGASSNTSDESMIETRCVLNSHSTAETTLDSFFSRAGLVGEIDLPLEGTTNPNGYANWDIDITGYAQMRRKVELFTYMRFDAEFTFVACTPTGEVVPQLLQYMFVPPGAPKPESRESLAWQTATNPSVFVKLTDPPAQVSVPFMSPASAYQWFYDGYPTFGEHKQEKDLEYGACPNNMMGTFSVRTVGSSKSKYPLVVRIYMRMKHVRAWIPRPMRNQNYLFKANPNYAGNSIKPTGTSRNAITTL | ||||||
Chain | PRO_0000039496 | 863-1012 | Protease 2A | |||
Sequence: GKFGQQSGAIYVGNFRVVNRHLATHNDWANLVWEDSSRDLLVSSTTAQGCDTIARCNCQTGVYYCNSKRKHYPVSFSKPSLIYVEASEYYPARYQSHLMLAAGHSESGDCGGILRCQHGVVGIASTGGNGLVGFADVRDLLWLDEEAMEQ | ||||||
Chain | PRO_0000426157 | 863-1440 | P2 | |||
Sequence: GKFGQQSGAIYVGNFRVVNRHLATHNDWANLVWEDSSRDLLVSSTTAQGCDTIARCNCQTGVYYCNSKRKHYPVSFSKPSLIYVEASEYYPARYQSHLMLAAGHSESGDCGGILRCQHGVVGIASTGGNGLVGFADVRDLLWLDEEAMEQGVSDYIKGLGDAFGTGFTDAVSREVEALRNHLIGSDGAVEKILKNLIKLISALVIVIRSDYDMVTLTATLALIGCHGSPWAWIKAKTASILGIPIAQKQSASWLKKFNDMASAAKGLEWISNKISKFIDWLREKIVPAAKEKAEFLTNLKQFPLLENQITHLEQSAASQEDLEAMFGNVSYLAHFCRKFQPLYATEAKRVYVLEKRMNNYMQFKSTHRIEPVCLIIRGSPGTGKSLATGIIARAIADKYHSSVYSLPPDPDHFDGYKQQVVTVMDDLCQNPDGKDMSLFYQMVSTVDIIPPMASLEEKGVSFTSKFVIASTNASNIIVPTVSDSDAIRRRFYMDCDIEVTDSSKTDLGRLDAGRAAKLCSENNTANFKRCSPLVCGKAIQLRDRKSKVRYSVDTVVSELIREYNSRSAIGNTIEALFQ | ||||||
Chain | PRO_0000039497 | 1013-1111 | Protein 2B | |||
Sequence: GVSDYIKGLGDAFGTGFTDAVSREVEALRNHLIGSDGAVEKILKNLIKLISALVIVIRSDYDMVTLTATLALIGCHGSPWAWIKAKTASILGIPIAQKQ | ||||||
Chain | PRO_0000039498 | 1112-1440 | Protein 2C | |||
Sequence: SASWLKKFNDMASAAKGLEWISNKISKFIDWLREKIVPAAKEKAEFLTNLKQFPLLENQITHLEQSAASQEDLEAMFGNVSYLAHFCRKFQPLYATEAKRVYVLEKRMNNYMQFKSTHRIEPVCLIIRGSPGTGKSLATGIIARAIADKYHSSVYSLPPDPDHFDGYKQQVVTVMDDLCQNPDGKDMSLFYQMVSTVDIIPPMASLEEKGVSFTSKFVIASTNASNIIVPTVSDSDAIRRRFYMDCDIEVTDSSKTDLGRLDAGRAAKLCSENNTANFKRCSPLVCGKAIQLRDRKSKVRYSVDTVVSELIREYNSRSAIGNTIEALFQ | ||||||
Chain | PRO_0000039499 | 1441-1526 | Protein 3A | |||
Sequence: GPPKFRPIRISLEEKPAPDAISDLLASVDSEEVRQYCREQGWIIPETPTNVERHLNRAVLVMQSIATVVAVVSLVYVIYKLFAGFQ | ||||||
Chain | PRO_0000426159 | 1441-1548 | Protein 3AB | |||
Sequence: GPPKFRPIRISLEEKPAPDAISDLLASVDSEEVRQYCREQGWIIPETPTNVERHLNRAVLVMQSIATVVAVVSLVYVIYKLFAGFQGAYSGAPNQVLKKPVLRTATVQ | ||||||
Chain | PRO_0000426158 | 1441-2193 | P3 | |||
Sequence: GPPKFRPIRISLEEKPAPDAISDLLASVDSEEVRQYCREQGWIIPETPTNVERHLNRAVLVMQSIATVVAVVSLVYVIYKLFAGFQGAYSGAPNQVLKKPVLRTATVQGPSLDFALSLLRRNIRQVQTDQGHFTMLGVRDRLAVLPRHSQPGKTIWVEHKLVNILDAAELVDEQGVNLELTLVTLDTNEKFRDITKFIPETISGASDATLVINTEHMPSMFVPVGDVVQYGFLNLSGKPTHRTMMYNFPTKAGQCGGVVTSVGKIIGIHIGGNGRQGFCAGLKRSYFASEQGEIQWVKSNKETGRLNINGPTRTKLEPSVFHDVFEANKEPAVLTSKDPRLEVDFEQALFSKYVGNVLHEPDEYVHQAALHYANQLKQLDINTKKMSMEEACYGTDNLEAIDLHTSAGYPYSALGIKKRDILDPATRDVSKMKSYMDKYGLDLPYSTYVKDELRSLDKIKKGKSRLIEASSLNDSVYLRMTFGHLYEVFHANPGTVTGSAVGCNPDVFWSKLPILLPGSLFAFDYSGYDASLSPVWFRALEVVLREIGYSEEAVSLIEGINHTHHIYRNKTYCVLGGMPSGCSGTSIFNSMINNIIIRTLLIKTFKGIDLDELNMVAYGDDVLASYPFPIDCLELAKTGKEYGLTMTPAGKSPCFNEVTWENATFLKRGFLPDHQFPFLIHPTMPMKEIHESIRWTKDARNTQDHVRSLCLLAWHNGKDEYEKFVSTIRSVPVGKALAIPNFENLRRNWLELF | ||||||
Chain | PRO_0000426160 | 1527-1548 | Viral protein genome-linked | |||
Sequence: GAYSGAPNQVLKKPVLRTATVQ | ||||||
Modified residue | 1529 | O-(5'-phospho-RNA)-tyrosine | ||||
Sequence: Y | ||||||
Chain | PRO_0000426162 | 1549-1731 | Protease 3C | |||
Sequence: GPSLDFALSLLRRNIRQVQTDQGHFTMLGVRDRLAVLPRHSQPGKTIWVEHKLVNILDAAELVDEQGVNLELTLVTLDTNEKFRDITKFIPETISGASDATLVINTEHMPSMFVPVGDVVQYGFLNLSGKPTHRTMMYNFPTKAGQCGGVVTSVGKIIGIHIGGNGRQGFCAGLKRSYFASEQ | ||||||
Chain | PRO_0000426161 | 1549-2193 | Protein 3CD | |||
Sequence: GPSLDFALSLLRRNIRQVQTDQGHFTMLGVRDRLAVLPRHSQPGKTIWVEHKLVNILDAAELVDEQGVNLELTLVTLDTNEKFRDITKFIPETISGASDATLVINTEHMPSMFVPVGDVVQYGFLNLSGKPTHRTMMYNFPTKAGQCGGVVTSVGKIIGIHIGGNGRQGFCAGLKRSYFASEQGEIQWVKSNKETGRLNINGPTRTKLEPSVFHDVFEANKEPAVLTSKDPRLEVDFEQALFSKYVGNVLHEPDEYVHQAALHYANQLKQLDINTKKMSMEEACYGTDNLEAIDLHTSAGYPYSALGIKKRDILDPATRDVSKMKSYMDKYGLDLPYSTYVKDELRSLDKIKKGKSRLIEASSLNDSVYLRMTFGHLYEVFHANPGTVTGSAVGCNPDVFWSKLPILLPGSLFAFDYSGYDASLSPVWFRALEVVLREIGYSEEAVSLIEGINHTHHIYRNKTYCVLGGMPSGCSGTSIFNSMINNIIIRTLLIKTFKGIDLDELNMVAYGDDVLASYPFPIDCLELAKTGKEYGLTMTPAGKSPCFNEVTWENATFLKRGFLPDHQFPFLIHPTMPMKEIHESIRWTKDARNTQDHVRSLCLLAWHNGKDEYEKFVSTIRSVPVGKALAIPNFENLRRNWLELF | ||||||
Chain | PRO_0000426163 | 1732-2193 | RNA-directed RNA polymerase | |||
Sequence: GEIQWVKSNKETGRLNINGPTRTKLEPSVFHDVFEANKEPAVLTSKDPRLEVDFEQALFSKYVGNVLHEPDEYVHQAALHYANQLKQLDINTKKMSMEEACYGTDNLEAIDLHTSAGYPYSALGIKKRDILDPATRDVSKMKSYMDKYGLDLPYSTYVKDELRSLDKIKKGKSRLIEASSLNDSVYLRMTFGHLYEVFHANPGTVTGSAVGCNPDVFWSKLPILLPGSLFAFDYSGYDASLSPVWFRALEVVLREIGYSEEAVSLIEGINHTHHIYRNKTYCVLGGMPSGCSGTSIFNSMINNIIIRTLLIKTFKGIDLDELNMVAYGDDVLASYPFPIDCLELAKTGKEYGLTMTPAGKSPCFNEVTWENATFLKRGFLPDHQFPFLIHPTMPMKEIHESIRWTKDARNTQDHVRSLCLLAWHNGKDEYEKFVSTIRSVPVGKALAIPNFENLRRNWLELF |
Post-translational modification
Genome polyprotein
Specific enzymatic cleavages in vivo by the viral proteases yield processing intermediates and the mature proteins.
Capsid protein VP0
Myristoylation is required for the formation of pentamers during virus assembly. Further assembly of 12 pentamers and a molecule of genomic RNA generates the provirion.
Capsid protein VP0
During virion maturation, immature virions are rendered infectious following cleavage of VP0 into VP4 and VP2. This maturation seems to be an autocatalytic event triggered by the presence of RNA in the capsid and it is followed by a conformational change infectious virion.
Capsid protein VP4
Myristoylation is required during RNA encapsidation and formation of the mature virus particle.
Viral protein genome-linked
VPg is uridylylated by the polymerase into VPg-pUpU. This acts as a nucleotide-peptide primer for the genomic RNA replication.
Keywords
- PTM
Interaction
Subunit
Capsid protein VP0
Interacts with capsid protein VP1 and capsid protein VP3 to form heterotrimeric protomers.
Capsid protein VP1
Interacts with capsid protein VP0, and capsid protein VP3 to form heterotrimeric protomers (By similarity).
Five protomers subsequently associate to form pentamers which serve as building blocks for the capsid (By similarity).
Interacts with capsid protein VP2, capsid protein VP3 and capsid protein VP4 following cleavage of capsid protein VP0 (By similarity).
Interacts with host SCARB2 (PubMed:30531980).
Interacts with host ARF6; this interaction mediates viral endocytosis (By similarity).
Five protomers subsequently associate to form pentamers which serve as building blocks for the capsid (By similarity).
Interacts with capsid protein VP2, capsid protein VP3 and capsid protein VP4 following cleavage of capsid protein VP0 (By similarity).
Interacts with host SCARB2 (PubMed:30531980).
Interacts with host ARF6; this interaction mediates viral endocytosis (By similarity).
Capsid protein VP2
Interacts with capsid protein VP1 and capsid protein VP3 in the mature capsid (By similarity).
Interacts with host SCARB2 (PubMed:30531980).
Interacts with host SCARB2 (PubMed:30531980).
Capsid protein VP3
Interacts with capsid protein VP0 and capsid protein VP1 to form heterotrimeric protomers (By similarity).
Five protomers subsequently associate to form pentamers which serve as building blocks for the capsid (By similarity).
Interacts with capsid protein VP4 in the mature capsid (By similarity).
Interacts with protein 2C; this interaction may be important for virion morphogenesis (By similarity).
Five protomers subsequently associate to form pentamers which serve as building blocks for the capsid (By similarity).
Interacts with capsid protein VP4 in the mature capsid (By similarity).
Interacts with protein 2C; this interaction may be important for virion morphogenesis (By similarity).
Capsid protein VP4
Interacts with capsid protein VP1 and capsid protein VP3.
Protease 2A
Homodimer.
Protein 2B
Interacts with host BAX; this interaction activates the mitochondrial apoptotic pathway. Interacts with host ILF2.
Protein 2C
Homohexamer; forms a hexameric ring structure with 6-fold symmetry characteristic of AAA+ ATPases (By similarity).
Interacts (via N-terminus) with host RTN3 (via reticulon domain); this interaction is important for viral replication (By similarity).
Interacts with capsid protein VP3; this interaction may be important for virion morphogenesis (By similarity).
Interacts (via N-terminus) with host RTN3 (via reticulon domain); this interaction is important for viral replication (By similarity).
Interacts with capsid protein VP3; this interaction may be important for virion morphogenesis (By similarity).
Protein 3AB
Interacts with protein 3CD.
Protein 3A
Homodimer (By similarity).
Interacts with host GBF1 (By similarity).
Interacts (via GOLD domain) with host ACBD3 (via GOLD domain); this interaction allows the formation of a viral protein 3A/ACBD3 heterotetramer with a 2:2 stoichiometry, which will stimulate the recruitment of host PI4KB in order to synthesize PI4P at the viral RNA replication sites (PubMed:31381608).
Interacts with host GBF1 (By similarity).
Interacts (via GOLD domain) with host ACBD3 (via GOLD domain); this interaction allows the formation of a viral protein 3A/ACBD3 heterotetramer with a 2:2 stoichiometry, which will stimulate the recruitment of host PI4KB in order to synthesize PI4P at the viral RNA replication sites (PubMed:31381608).
Viral protein genome-linked
Interacts with RNA-directed RNA polymerase.
Protease 3C
Interacts with host IFIH1/MDA5; this interaction inhibits host IFIH1.
Protein 3CD
Interacts with protein 3AB and with RNA-directed RNA polymerase.
RNA-directed RNA polymerase
Interacts with Viral protein genome-linked and with protein 3CD.
Structure
Family & Domains
Features
Showing features for region, domain, zinc finger.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Region | 1-22 | Disordered | ||||
Sequence: MGSQVSTQRSGSHENSNSATEG | ||||||
Region | 568-588 | Amphipathic alpha-helix | ||||
Sequence: RVADVIESSIGDSVSRALTQA | ||||||
Domain | 1216-1374 | SF3 helicase | ||||
Sequence: EKRMNNYMQFKSTHRIEPVCLIIRGSPGTGKSLATGIIARAIADKYHSSVYSLPPDPDHFDGYKQQVVTVMDDLCQNPDGKDMSLFYQMVSTVDIIPPMASLEEKGVSFTSKFVIASTNASNIIVPTVSDSDAIRRRFYMDCDIEVTDSSKTDLGRLDA | ||||||
Zinc finger | 1381-1397 | C4-type; degenerate | ||||
Sequence: CSENNTANFKRCSPLVC | ||||||
Domain | 1549-1727 | Peptidase C3 | ||||
Sequence: GPSLDFALSLLRRNIRQVQTDQGHFTMLGVRDRLAVLPRHSQPGKTIWVEHKLVNILDAAELVDEQGVNLELTLVTLDTNEKFRDITKFIPETISGASDATLVINTEHMPSMFVPVGDVVQYGFLNLSGKPTHRTMMYNFPTKAGQCGGVVTSVGKIIGIHIGGNGRQGFCAGLKRSYF | ||||||
Domain | 1958-2073 | RdRp catalytic | ||||
Sequence: GSLFAFDYSGYDASLSPVWFRALEVVLREIGYSEEAVSLIEGINHTHHIYRNKTYCVLGGMPSGCSGTSIFNSMINNIIIRTLLIKTFKGIDLDELNMVAYGDDVLASYPFPIDCL |
Domain
Protein 2C
The N-terminus has membrane-binding (By similarity).
The N-terminus also displays RNA-binding properties (By similarity).
The N-terminus is involved in oligomerization (By similarity).
The central part contains an ATPase domain and a degenerate C4-type zinc-finger with only 3 cysteines (By similarity).
The C-terminus is involved in RNA-binding (By similarity).
The extreme C-terminus contains a region involved in oligomerization (By similarity).
The N-terminus also displays RNA-binding properties (By similarity).
The N-terminus is involved in oligomerization (By similarity).
The central part contains an ATPase domain and a degenerate C4-type zinc-finger with only 3 cysteines (By similarity).
The C-terminus is involved in RNA-binding (By similarity).
The extreme C-terminus contains a region involved in oligomerization (By similarity).
Sequence similarities
Belongs to the picornaviruses polyprotein family.
Keywords
- Domain
Family and domain databases
Sequence
- Sequence statusComplete
- Length2,193
- Mass (Da)242,657
- Last updated2007-01-23 v3
- Checksum35E1B3CFF88A50EF
Keywords
- Technical term